Maureen J. Lage, PhD

Previous research overstated the generalizability of the Exenatide Study of Cardiovascular Event Lowering trial results by omitting the restriction on the percentage of patients without a prior cardiovascular event.

Adherence to glucose-lowering agents was associated with a significant reduction in use of acute care resources without any increased total medical costs.

The analysis examines the annual economic effect of medically treating patients with prostate cancer and subsequent bone metastases.